Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,377 Results (Page 56 of 119)
- Relevance
  Sort by

North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
83 Pages
North America

From

€1327EUR$1,500USD£1,151GBP

Europe Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
93 Pages
Europe

From

€1327EUR$1,500USD£1,151GBP

LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
93 Pages
Middle East, Africa

From

€1327EUR$1,500USD£1,151GBP

Leukemia Targeted Therapy Drugs Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030

 Report
August 2025
189 Pages
Global

From

€3136EUR$3,545USD£2,721GBP

€3485EUR$3,939USD£3,023GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7034EUR$7,950USD£6,102GBP

Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3672EUR$4,150USD£3,185GBP

Myelodysplastic Syndrome - Pipeline Review, H1 2020

 Drug Pipelines
June 2020
1667 Pages
Global

From

€1769EUR$2,000USD£1,535GBP

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3097EUR$3,500USD£2,686GBP

Myelodysplastic Syndrome Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Acute Myeloid Leukemia Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
180 Pages
Global

From

€3981EUR$4,500USD£3,454GBP

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
152 Pages
Global

From

€3097EUR$3,500USD£2,686GBP

Alzheimer's Disease Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
117 Pages
Global

From

€4202EUR$4,750USD£3,646GBP

Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
230 Pages
Global

From

€2654EUR$3,000USD£2,302GBP

Asia Pacific Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
94 Pages
Asia Pacific

From

€1327EUR$1,500USD£1,151GBP

Genitourinary Drugs Market Report by Indication, Product, and Region 2025-2033

 Report
September 2025
146 Pages
Global

From

€3538EUR$3,999USD£3,069GBP

Multiple Myeloma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

2,377 Results (Page 56 of 119)
- 1
- 54
- 55
- 56
- 57
- 58

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.